
Novo Nordisk sales of leading products 2024
Danish drug manufacturer Novo Nordisk's top product Ozempic - a glucagon-like peptide 1 - generated some 120 billion kroner in sales in 2024. Another GLP-1 product, Rybelsus, was the company's third best-selling product.